Dupilumab leads to no or low disease activity in most moderate-to-severe atopic dermatitis patients: signs, symptoms and quality of life

被引：0

作者：

Blauvelt, A. ^{[1
]}

Chen, Z. ^{[2
]}

Hultsch, T. ^{[3
]}

Eckert, L. ^{[4
]}

Gadkari, A. ^{[2
]}

Shumel, B. ^{[2
]}

Ardeleanu, M. ^{[2
]}

机构：

[1] Oregon Med Res Ctr, Portland, OR USA

[2] Regeneron Pharmaceut, Tarrytown, NY USA

[3] Sanofi Genzyme, Cambridge, MA USA

[4] Sanofi, Chilly Mazarin, France

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2018年 / 179卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P079

引用

页码：60 / 60

页数：1

共 50 条

[41] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Andreas Kuznik
Gaëlle Bégo-Le-Bagousse
Laurent Eckert
Abhijit Gadkari
Eric Simpson
Christopher N. Graham
LaStella Miles
Vera Mastey
Puneet Mahajan
Sean D. Sullivan
Dermatology and Therapy, 2017, 7 : 493 - 505
[42] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
不详
BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4
[43] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
Berdyshev, Evgeny
Goleva, Elena
Bissonnette, Robert
Bronova, Irina
Bronoff, Anna Sofia
Richers, Brittany N.
Garcia, Shannon
Ramirez-Gama, Marco
Taylor, Patricia
Praestgaard, Amy
Agueusop, Inoncent
Jurvilliers, Pauline
Boguniewicz, Mark
Levit, Noah A.
Rossi, Ana B.
Zhang, Annie
Leung, Donald Y. M.
ALLERGY, 2022, 77 (11) : 3388 - 3397
[44] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Kuznik, Andreas
Bego-Le-Bagousse, Gaelle
Eckert, Laurent
Gadkari, Abhijit
Simpson, Eric
Graham, Christopher N.
Miles, LaStella
Mastey, Vera
Mahajan, Puneet
Sullivan, Sean D.
DERMATOLOGY AND THERAPY, 2017, 7 (04) : 493 - 505
[45] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis
Silverberg, Jonathan, I
Rubini, Norma P. M.
Pires, Mario C.
Rossi, Ana B.
Zhang, Annie
Chen, Zhen
Levit, Noah A.
Chao, Jingdong
Shumel, Brad
Bego-Le Bagousse, Gaelle
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
[46] Dupilumab monotherapy improves signs, symptoms and quality of life in adult and adolescent patients with erythrodermic atopic dermatitis
Shabbir, A.
Paller, A. S.
Lockshin, B.
Cork, M. J.
Morren, M.
Kataoka, Y.
Chen, Z.
Rossi, A. B.
Lu, Y.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S60 - S60
[47] Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis
Miniotti, Marco
Lazzarin, Giulia
Ortoncelli, Michela
Mastorino, Luca
Ribero, Simone
Leombruni, Paolo
DERMATOLOGIC THERAPY, 2022, 35 (05)
[48] Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment
Merola, Joseph F.
Chiou, Albert S.
During, Emmanuel
Costanzo, Antonio
Foley, Peter
Ardeleanu, Marius
Wu, Jiangming
Ozturk, Zafer E.
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[49] Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
Lio, Peter A.
Armstrong, April
Gutermuth, Jan
Nosbaum, Audrey
Sofen, Howard
Gil, Esther Garcia
Casillas, Marta
Chen, Sherry
Sun, Luna
Pierce, Evangeline
Elmaraghy, Hany
Dawson, Zach
Torres, Tiago
DERMATOLOGY AND THERAPY, 2024, 14 (07) : 1929 - 1943
[50] Dupilumab Improves Family Quality of Life in Children Aged 6 months to 5 Years With Moderate-to-Severe Atopic Dermatitis
Paller, Amy
Simpson, Eric
Siegfried, Elaine
Preastgaard, Amy
Wang, Zhixiao
Prescilla, Randy
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB150 - AB150

← 1 2 3 4 5 →